A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1998

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Interleukin-4

Trial Locations (3)

UCLA CARE Center CRS, Los Angeles

Massachusetts General Hospital ACTG CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000769 - A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter